We’re experts in genetics, so you don’t have to be

Buy Color

Our state-of-the art genomics lab is optimized
for efficiency and accuracy

By combining lab automation and custom software with a deep knowledge of science, we offer one of the most accessible, clinical-grade genetic services available today.

>99% accuracy

clinical tests scientifically validated

10+ issued patents

covering our proprietary technology

Recognized

by World Economic Forum as a technology pioneer

10-15% of most cancers are due to genetic mutations, or changes, that are passed down from parents.1, 2, 3, 4

  • Genetic mutations can greatly increase your risk for developing cancer.
  • For example, a BRCA1 mutation can increase a woman’s chance of breast cancer up to 81% by age 80.5
  • Color selected 30 genes strongly linked to the 8 most common hereditary cancers.

Learn more about cancer ›

Most cases of heart disease are due to a combination of lifestyle choices, but some are due to genetics.

 

  • Many people with genetic heart conditions often don’t experience symptoms and don’t know they’re at risk.
  • 1 in 50 adults with high cholesterol have a different, genetic form that doesn’t respond as much to eating healthy or exercise.6
  • Color includes 30 genes that were recognized by the American College of Medical Genetics and Genomics as having actionable treatment plans.*

Learn more about heart ›

When you take a medication, your response is influenced by many factors including genetics.

 

  • Factors like body size, other medications, and health history along with your genes can all impact how your body metabolizes certain medications.
  • Color has selected genes that can influence how the body processes certain commonly prescribed medications.7
  • Always talk to your doctor before making changes to your medications.

Learn more about medication response ›

Be confident you’re getting the whole BRCA
story

Imagine that each gene is like a book. You need to read the whole book to know the story. For the
genes in Color’s panel, you’re reading more than just a few pages.

Don’t settle for just a few pages.
For example, recreational tests only look at 3 pages of the BRCA1 and BRCA2 “books”, giving you an incomplete picture.

Read the whole book.
Color looks at the whole “book” for these 2 genes, covering all of their 10,000+ known pages.

Get the same science used to power ground-breaking research

USCF / WISDOM

Aiming to make breast cancer
screening more effective by studying
100,000 women.

SU2C / MAGENTA

Designed to prevent cancer in high-
risk women by increasing access to genetic testing.

UW / GENTleMEN

Seeks to find more effective treatments for men with metastatic prostate cancer.

Take a look at some of the science we’ve published with leading researchers

Ready to purchase Color?

Get to know what your genes say about your risk for common hereditary cancers and heart conditions, plus medication responses.

Buy Color
REFERENCES
1. Tung N, Battelli C, Allen B, et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer. January 2015;121(1):25-33. Pubmed Abstract.
2. Pal T, Permuth-Wey J, Betts JA, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer. December 2005;104(12):2807-16. Pubmed Abstract.
3. Claus EB, Risch N, Thompson WD, et al. The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat. November 1993;28(2):115-20. Pubmed Abstract.
4. Risch HA, McLaughlin JR, Cole DE, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet. March 2001;68(3):700-10. Pubmed Abstract.
5. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302(5645):643-6. Pubmed Abstract.
6. Khera AV, Won HH, Peloso GM, et al. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia. J Am Coll Cardiol. 2016;67(22):2578-89.
7. PharmGKB. Guideline Annotations. Accessed September 25, 2018. https://www.pharmgkb.org/guidelines.

* Risk information and screening guidelines in results are typically based on studies of individuals with a family history of the disorder being discussed. Medical management should be considered also taking into account on your personal and family history.